Beyond Medical Technologies Inc. (CSE:DOCT)
0.4000
0.00 (0.00%)
May 16, 2025, 9:49 AM EDT
CSE:DOCT Statistics
Total Valuation
CSE:DOCT has a market cap or net worth of CAD 9.12 million. The enterprise value is 9.15 million.
Market Cap | 9.12M |
Enterprise Value | 9.15M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 23.31M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 15.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -14.69 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -32.00 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -468.48% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 66.09% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,042.86% in the last 52 weeks. The beta is 7,787.89, so CSE:DOCT's price volatility has been higher than the market average.
Beta (5Y) | 7,787.89 |
52-Week Price Change | +1,042.86% |
50-Day Moving Average | 0.19 |
200-Day Moving Average | 0.08 |
Relative Strength Index (RSI) | 82.18 |
Average Volume (20 Days) | 50,562 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -410,175 |
Pretax Income | -365,881 |
Net Income | -285,943 |
EBITDA | n/a |
EBIT | -410,175 |
Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 13,218 in cash and 60,000 in debt, giving a net cash position of -46,782.
Cash & Cash Equivalents | 13,218 |
Total Debt | 60,000 |
Net Cash | -46,782 |
Net Cash Per Share | n/a |
Equity (Book Value) | -620,659 |
Book Value Per Share | -0.08 |
Working Capital | -620,659 |
Cash Flow
Operating Cash Flow | -109,770 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:DOCT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -3.14% |
FCF Yield | n/a |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.1.
Last Split Date | Dec 30, 2022 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |